Semi-automatic thresholding of RV trabeculation improves repeatability and diagnostic value in suspected pulmonary hypertension.

cardiac MRI diagnosis pulmonary hypertension right ventricle trabeculation

Journal

Frontiers in cardiovascular medicine
ISSN: 2297-055X
Titre abrégé: Front Cardiovasc Med
Pays: Switzerland
ID NLM: 101653388

Informations de publication

Date de publication:
2022
Historique:
received: 05 09 2022
accepted: 13 12 2022
entrez: 23 1 2023
pubmed: 24 1 2023
medline: 24 1 2023
Statut: epublish

Résumé

Right ventricle (RV) mass is an imaging biomarker of mean pulmonary artery pressure (MPAP) and pulmonary vascular resistance (PVR). Some methods of RV mass measurement on cardiac MRI (CMR) exclude RV trabeculation. This study assessed the reproducibility of measurement methods and evaluated whether the inclusion of trabeculation in RV mass affects diagnostic accuracy in suspected pulmonary hypertension (PH). Two populations were enrolled prospectively. (i) A total of 144 patients with suspected PH who underwent CMR followed by right heart catheterization (RHC). Total RV mass (including trabeculation) and compacted RV mass (excluding trabeculation) were measured on the end-diastolic CMR images using both semi-automated pixel-intensity-based thresholding and manual contouring techniques. (ii) A total of 15 healthy volunteers and 15 patients with known PH. Interobserver agreement and scan-scan reproducibility were evaluated for RV mass measurements using the semi-automated thresholding and manual contouring techniques. Total RV mass correlated more strongly with MPAP and PVR ( Using a semi-automated thresholding technique, inclusion of trabecular mass and indexing RV mass for LV mass (ventricular mass index), improves the diagnostic accuracy of CMR measurements in suspected PH.

Identifiants

pubmed: 36684562
doi: 10.3389/fcvm.2022.1037385
pmc: PMC9845927
doi:

Types de publication

Journal Article

Langues

eng

Pagination

1037385

Subventions

Organisme : Medical Research Council
ID : MR/M008894/1
Pays : United Kingdom
Organisme : British Heart Foundation
ID : SP/14/6/31350
Pays : United Kingdom

Informations de copyright

Copyright © 2023 Macdonald, Salehi, Alabed, Maiter, Goh, Dwivedi, Johns, Cogliano, Alandejani, Condliffe, Wild, Kiely, Garg and Swift.

Déclaration de conflit d'intérêts

The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.

Références

J Cardiovasc Magn Reson. 2014 Oct 01;16:74
pubmed: 25315015
J Cardiovasc Magn Reson. 2012 Jun 21;14:40
pubmed: 22720870
Front Cardiovasc Med. 2022 Mar 25;9:797561
pubmed: 35402574
Eur Respir J. 2019 Jan 24;53(1):
pubmed: 30545968
J Anat. 2022 Feb;240(2):357-375
pubmed: 34569075
Int J Cardiovasc Imaging. 2018 Jul;34(7):1127-1133
pubmed: 29492774
Thorax. 2021 Oct;76(10):1032-1035
pubmed: 33632769
Invest Radiol. 2011 Sep;46(9):567-75
pubmed: 21577127
Chest. 2011 Aug;140(2):310-316
pubmed: 21330384
Int J Cardiovasc Imaging. 2014 Mar;30(3):599-608
pubmed: 24442769
Radiology. 2005 Jul;236(1):57-64
pubmed: 15955850
J Cardiovasc Magn Reson. 2022 Apr 7;24(1):25
pubmed: 35387651
JACC Cardiovasc Imaging. 2021 May;14(5):931-942
pubmed: 33008758
Int J Cardiovasc Imaging. 2013 Mar;29(3):625-31
pubmed: 22945368
Heart. 2022 Aug 11;108(17):1392-1400
pubmed: 35512982
Eur Heart J. 2016 Jan 1;37(1):67-119
pubmed: 26320113
J Chiropr Med. 2016 Jun;15(2):155-63
pubmed: 27330520
J Am Coll Cardiol. 2011 Feb 22;57(8):921-8
pubmed: 21329838
Echocardiography. 2017 Feb;34(2):290-295
pubmed: 28168751
Int J Cardiovasc Imaging. 2018 Sep;34(9):1439-1449
pubmed: 29605901
Front Med (Lausanne). 2022 Mar 14;9:840196
pubmed: 35360708
JACC Cardiovasc Imaging. 2021 Jun;14(6):1271-1272
pubmed: 33221232
Int J Cardiovasc Imaging. 2014 Feb;30(2):357-65
pubmed: 24306052
Radiology. 2018 Aug;288(2):386-395
pubmed: 29869959
Eur Respir J. 2013 Jun;41(6):1292-301
pubmed: 23018917
Eur Respir J. 2002 Dec;20(6):1519-24
pubmed: 12503713
J Cardiovasc Magn Reson. 2008 Aug 19;10:40
pubmed: 18713464
Am J Cardiol. 2002 Jul 1;90(1):29-34
pubmed: 12088775
J Magn Reson Imaging. 2010 Jan;31(1):117-24
pubmed: 20027579

Auteurs

Alistair Macdonald (A)

Department of Infection, Immunity and Cardiovascular Disease, The University of Sheffield, Sheffield, United Kingdom.
Department of Clinical Radiology, Sheffield Teaching Hospitals, Sheffield, United Kingdom.

Mahan Salehi (M)

Department of Infection, Immunity and Cardiovascular Disease, The University of Sheffield, Sheffield, United Kingdom.
Department of Clinical Radiology, Sheffield Teaching Hospitals, Sheffield, United Kingdom.

Samer Alabed (S)

Department of Infection, Immunity and Cardiovascular Disease, The University of Sheffield, Sheffield, United Kingdom.
Department of Clinical Radiology, Sheffield Teaching Hospitals, Sheffield, United Kingdom.
INSIGNEO, Institute for in Silico Medicine, The University of Sheffield, Sheffield, United Kingdom.

Ahmed Maiter (A)

Department of Infection, Immunity and Cardiovascular Disease, The University of Sheffield, Sheffield, United Kingdom.
Department of Clinical Radiology, Sheffield Teaching Hospitals, Sheffield, United Kingdom.

Ze Ming Goh (ZM)

Department of Infection, Immunity and Cardiovascular Disease, The University of Sheffield, Sheffield, United Kingdom.
Department of Clinical Radiology, Sheffield Teaching Hospitals, Sheffield, United Kingdom.

Krit Dwivedi (K)

Department of Infection, Immunity and Cardiovascular Disease, The University of Sheffield, Sheffield, United Kingdom.
Department of Clinical Radiology, Sheffield Teaching Hospitals, Sheffield, United Kingdom.

Chris Johns (C)

Department of Infection, Immunity and Cardiovascular Disease, The University of Sheffield, Sheffield, United Kingdom.

Marcella Cogliano (M)

Department of Infection, Immunity and Cardiovascular Disease, The University of Sheffield, Sheffield, United Kingdom.

Faisal Alandejani (F)

Department of Infection, Immunity and Cardiovascular Disease, The University of Sheffield, Sheffield, United Kingdom.

Robin Condliffe (R)

Sheffield Pulmonary Vascular Disease Unit, Royal Hallamshire Hospital, Sheffield, United Kingdom.

James M Wild (JM)

Department of Infection, Immunity and Cardiovascular Disease, The University of Sheffield, Sheffield, United Kingdom.

David G Kiely (DG)

Department of Infection, Immunity and Cardiovascular Disease, The University of Sheffield, Sheffield, United Kingdom.
Sheffield Pulmonary Vascular Disease Unit, Royal Hallamshire Hospital, Sheffield, United Kingdom.

Pankaj Garg (P)

Norwich Medical School, University of East Anglia, Norwich, United Kingdom.

Andrew J Swift (AJ)

Department of Infection, Immunity and Cardiovascular Disease, The University of Sheffield, Sheffield, United Kingdom.
INSIGNEO, Institute for in Silico Medicine, The University of Sheffield, Sheffield, United Kingdom.

Classifications MeSH